Early detection of metastatic disease in asymptomatic breast cancer patients with whole-body imaging and defined tumour marker increase

Por Di Gioia, D, Stieber, P, Schmidt, G P, Nagel, D, Heinemann, V, Baur-Melnyk, A
Publicado no Br J Cancer (2015)

Randomised phase II trial of gemcitabine plus vinorelbine vs gemcitabine plus cisplatin vs gemcitabine plus capecitabine in patients with pretreated metastatic breast cancer

Por Stemmler, H J, diGioia, D, Freier, W, Tessen, H W, Gitsch, G, Jonat, W, Brugger, W, Kettner, E, Abenhardt, W, Tesch, H, Hurtz, H J, Rösel, S, Brudler, O, Heinemann, V
Publicado em 2011

A phase II, multicentre trial of decitabine in higher-risk chronic myelomonocytic leukemia

Por Santini, V, Allione, B, Zini, G, Gioia, D, Lunghi, M, Poloni, A, Cilloni, D, Sanna, A, Masiera, E, Ceccarelli, M, Abdel-Wahab, O, Terenzi, A, Angelucci, E, Finelli, C, Onida, F, Pelizzari, A, Ferrero, D, Saglio, G, Figueroa, M, Levis, A
Publicado no Leukemia (2018)